Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mohamed Samir Abd Elghafar"'
Autor:
Doaa Ezzat Mohamed Elbarbary, Mona Mohamed Watany, Mohamed Samir Abd Elghafar, Manal Abd Elwahed Eid
Publikováno v:
The Egyptian Journal of Hospital Medicine. 90:1356-1364
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::866cd04a9e2322629a1daed1cde9663b
https://doi.org/10.21608/ejhm.2023.282149
https://doi.org/10.21608/ejhm.2023.282149
Autor:
Shimaa Elsharawy, Amany Ghazi, Ibrahim Amer, Walaa Mowafy El-Lawaty, Mohamed Samir Abd Elghafar, Marwa Salama, Nehad Hawash
Publikováno v:
Afro-Egyptian Journal of Infectious and Endemic Diseases. :284-294
Background and study aim: The incremental global spread of the SARS-CoV-2 virus imposes an enormous burden on medical health systems. We focused on determining the predictors for the COVID-19 patient's course of illness and what level of car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4705e825b206f5c1c8a8782d4bdc854
https://doi.org/10.21608/aeji.2021.82473.1155
https://doi.org/10.21608/aeji.2021.82473.1155
Autor:
Mohamed AbdAllah, Mahmoud Essam, Mohamed Samir Abd Elghafar, Tamer Elhadidy, Gamal Esmat, Marwa Salama, Tamer Elbaz, Mustafa Neamatallah, Mostafa Elshazly, Ahmed Cordie, Mahmoud El-Bendary, Wafaa El-Akel, Khaled Farid, Mohamed Elegezy, Adel El-Badrawy, Sherief Abd-Elsalam, Hatem Elalfy
Publikováno v:
Expert Review of Anti-infective Therapy. 20:291-295
Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating CO...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::812d196460d07fac296b2f47aa8ecd28
https://doi.org/10.1080/14787210.2021.1950532
https://doi.org/10.1080/14787210.2021.1950532
Publikováno v:
Anti-Infective Agents. 20
Background: Coagulase-negative Staphylococci (CoNS) is one of the major causes of infections in hospitals. Methicillin resistance has greatly increased in different CoNS species in previous years. Here, we evaluated the performance of four phenotypic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe8d61cb2f919a8dc515bc0b351109bc
https://doi.org/10.2174/2211352519666210715150507
https://doi.org/10.2174/2211352519666210715150507
Autor:
Wafaa M. Abdelwahed, Salah El-din I. Alsherif, Yasser M Amr, Mohamed Samir Abd Elghafar, Mohamed A. Eltomey
Publikováno v:
Journal of Critical Care. 52:10-15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208c10f2798e1a697903296eb9d82594
https://doi.org/10.1016/j.jcrc.2019.03.006
https://doi.org/10.1016/j.jcrc.2019.03.006
Autor:
Mohamed Tawfik, Ahmed Esam, Amira Youssef, Mohammed Fawzi Abosamak, Alzahraa A Allam, Hossam Hodeib, Sameh Samir, Ola A Elshora, Amal Selim, Mohamed Samir Abd Elghafar
Publikováno v:
Genes, Vol 12, Iss 874, p 874 (2021)
Genes
Volume 12
Issue 6
Genes
Volume 12
Issue 6
Introduction: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and/or pulmonary embolism (PE), is a common, acute, multifactorial disease with a five-years cumulative incidence of recurrence of approximately 25%. Actually, no single
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b45f154536011bf1cc3948797479058
https://doi.org/10.3390/genes12060874
https://doi.org/10.3390/genes12060874
Autor:
A. Hagras, Maii A. Shams Eldeen, Walaa M. Shehata, Mohamed Samir Abd Elghafar, Marwa M. E. Abd-Elmonsef
Publikováno v:
International Journal of Current Microbiology and Applied Sciences. 5:452-464
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89420fb3bf2159a728a4e7e6a20b4e66
https://doi.org/10.20546/ijcmas.2016.512.049
https://doi.org/10.20546/ijcmas.2016.512.049